Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,338,000 | 4,362,000 | 4,893,000 | 4,065,000 | 5,997,000 |
| Marketable Securities | 1,182,000 | 1,376,000 | 1,632,000 | 1,601,000 | 1,411,000 |
| Receivables | 4,493,000 | 4,566,000 | 4,149,000 | 3,925,000 | 4,892,000 |
| Inventories | 1,618,000 | 1,676,000 | 1,772,000 | 1,779,000 | 1,683,000 |
| TOTAL | $14,772,000 | $13,991,000 | $13,925,000 | $13,278,000 | $15,996,000 |
| Non-Current Assets | |||||
| PPE Net | 5,121,000 | 5,037,000 | 4,996,000 | 4,990,000 | 4,967,000 |
| Investments And Advances | 1,309,000 | 1,099,000 | 836,000 | 579,000 | 502,000 |
| Intangibles | 41,787,000 | 42,232,000 | 42,675,000 | 43,115,000 | 41,234,000 |
| Other Non-Current Assets | 4,963,000 | 4,739,000 | 5,552,000 | 5,530,000 | 5,708,000 |
| TOTAL | $53,180,000 | $53,107,000 | $54,059,000 | $54,214,000 | $52,411,000 |
| Total Assets | $67,952,000 | $67,098,000 | $67,984,000 | $67,492,000 | $68,407,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,516,000 | 2,511,000 | 2,261,000 | 2,259,000 | 2,757,000 |
| Accounts payable and accrued liabilities | 705,000 | 585,000 | 608,000 | 570,000 | 844,000 |
| Accrued Expenses | 3,244,000 | 3,368,000 | 3,290,000 | 3,369,000 | 3,460,000 |
| TOTAL | $11,610,000 | $10,245,000 | $10,214,000 | $9,705,000 | $11,397,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,155,000 | 26,137,000 | 27,914,000 | 29,337,000 | 29,859,000 |
| Other Non-Current Liabilities | 4,773,000 | 4,648,000 | 5,777,000 | 5,029,000 | 5,023,000 |
| TOTAL | $35,278,000 | $35,382,000 | $38,060,000 | $38,823,000 | $38,789,000 |
| Total Liabilities | $46,888,000 | $45,627,000 | $48,274,000 | $48,528,000 | $50,186,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,253,887 | 1,254,383 | 1,253,809 | 1,254,178 | 1,256,593 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 16,324,000 | 16,903,000 | 15,392,000 | 14,821,000 | 14,381,000 |
| Other shareholders' equity | 78,000 | 75,000 | 46,000 | 50,000 | -41,000 |
| TOTAL | $21,064,000 | $21,471,000 | $19,710,000 | $18,964,000 | $18,221,000 |
| Total Liabilities And Equity | $67,952,000 | $67,098,000 | $67,984,000 | $67,492,000 | $68,407,000 |